D-0052-2018 Class III Terminated
FDA drug recall D-0052-2018 was initiated by Teva Pharmaceuticals USA on Oct 17, 2017 and is designated Class III. Reason for recall: Failed Dissolution Specifications: Low out of specification results for dissolution. The recall status is terminated (terminated Apr 12, 2018). Affected quantity: 58,292 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 1, 2017
- Initiation Date
- Oct 17, 2017
- Termination Date
- Apr 12, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 58,292 bottles
Product description
Methylphenidate Hydrochloride Tablets USP, 20 mg, 100-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA, NDC 0591-5884-01.
Reason for recall
Failed Dissolution Specifications: Low out of specification results for dissolution.
Distribution pattern
Nationwide in the USA and Puerto Rico
Code information
Lot Number # 1156086M, Exp 08/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0052-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026